Psychoactive drug use in nursing homes

被引:4
|
作者
Garolera, D
Bendahan, G
Gras, R
Benaque, A
San José, A
Vilardell, M
机构
[1] Inst Catala Salut, Unitat Atencio Domiciliaria Geriatr, CAP Manso DAP Eixample, Direcc Atencion Primaria Eixample, Barcelona 08015, Spain
[2] Hosp Univ Vall dHebron, Med Interna Serv, Unidad Geriatria, Barcelona, Spain
来源
MEDICINA CLINICA | 2001年 / 117卷 / 16期
关键词
nursing home; psychoactive drugs; neuroleptics; antidepressants; benzodiazepines; inappropriate use;
D O I
10.1016/S0025-7753(01)72196-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Our purpose was to know the use of psychoactive drugs including neuroleptics (NL), benzodiazepines (BNZ) and antidepressants (AD) In nursing homes (NH) in the city of Barcelona. METHOD: Cross-sectional descriptive study of 384 clinical records of people living in 19 NH. The correct use of drugs was estimated by Garrad's and Beers at al criteria. RESULTS: Average age (SD) of residents was 83 years (2.0). The average consumption of drugs was 5 (2.7); 248 individuals (64.6%) were taking at least one psychoactive drug: 81 (21%) consumed NL, 179 (46.6%) BNZ and 73 (19%) AD. 48 (12.5%) NH residents consumed long-acting BNZ and 26 (6.7%) had surpassed the recommended time of consumption for short-acting BNZ. In 21 (26%) NH residents who consumed NL, its use would not be justified. CONCLUSIONS. It is necessary to reduce the use of long-acting BNZ, to encourage a correct use of NL and to achieve a correct identification of depressive disorders in NH.
引用
收藏
页码:615 / 616
页数:2
相关论文
共 50 条
  • [1] REDUCTION OF PSYCHOACTIVE DRUG-USE IN NURSING-HOMES THROUGH ACADEMIC DETAILING
    AVORN, J
    SOUMERAI, SB
    EVERITT, DE
    SHERMAN, DS
    BEERS, MH
    SALEM, SR
    [J]. CLINICAL RESEARCH, 1988, 36 (03): : A331 - A331
  • [2] USE OF PSYCHOACTIVE-DRUGS IN NURSING-HOMES
    PIES, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (19): : 1392 - 1392
  • [3] Effects of a restraint reduction intervention and OBRA '87 regulations on psychoactive drug use in nursing homes
    Siegler, EL
    Capezuti, E
    Maislin, G
    Baumgarten, M
    Evans, L
    Strumpf, N
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (07) : 791 - 796
  • [4] USE OF PSYCHOACTIVE-DRUGS IN NURSING-HOMES - REPLY
    AVORN, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (19): : 1393 - 1393
  • [5] Drug Use in Swedish Nursing Homes
    Cecilia B. Claesson
    Ingrid K. Schmidt
    [J]. Clinical Drug Investigation, 1998, 16 : 441 - 452
  • [6] Psychotropic drug use in nursing homes
    Pantel, Johannes
    Grell, Alexander
    Haberstroh, Julia
    [J]. PSYCHOPHARMAKOTHERAPIE, 2010, 17 (02): : 76 - +
  • [7] Drug use in Swedish nursing homes
    Claesson, CB
    Schmidt, IK
    [J]. CLINICAL DRUG INVESTIGATION, 1998, 16 (06) : 441 - 452
  • [8] Psychotropic drug use in residential and nursing homes
    Riedel-Heller, SG
    Stelzner, G
    Schork, A
    Angermeyer, MC
    [J]. PSYCHIATRISCHE PRAXIS, 1999, 26 (06) : 273 - 276
  • [9] Drug use in nursing homes: compliance between diagnosis, indication and drug use
    Ahmed, Yasin
    Halvorsen, Kjell H.
    Svendsen, Kristian
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 248 - 249
  • [10] Drug use in nursing homes: Some new evidence
    Mant, A
    Donnelly, NJ
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1996, 165 (05) : 295 - 296